SOPA 2022 Journalism Awards Open for Entries; Deadline 17 Feb
HONG KONG--(BUSINESS WIRE)--#SOPAwards2022--The Society of Publishers in Asia (SOPA), a not-for-profit organization dedicated to the…
5 years ago
Murata and Michelin Co-develop RFID Module to Improve Tire Management Operations
Michelin co-develops RFID module to improve tire management operations KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd.…
5 years ago
KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform
GOYANG, South Korea--(BUSINESS WIRE)--#BioPharmaExhibition--KOREA PACK and concurrent event ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry…
5 years ago
Confluent and Alibaba Cloud Announce Partnership to set Data in Motion in Mainland China
SINGAPORE--(BUSINESS WIRE)--Confluent, Inc. (NASDAQ: CFLT), the platform for data in motion, and Alibaba Cloud, the…
5 years ago
GLIDE: End of Malaria and Lymphatic Filariasis in Sight for Philippines, Says Award-winning Filipino Doctor
? Dr Fe Esperanza Espino is one of five winners selected to win a Falcon…
5 years ago
Leading Cosmetics Brand Pula Enters the Chinese Market
TOKYO, JAPAN - Media OutReach - 13 December 2021 - Recently, Pula, a well-known Japanese cosmetics brand…
5 years ago
Understanding the Hehe Culture and A Community of Shared Future for Mankind in Taizhou, Zhejiang
TAIZHOU, China--(BUSINESS WIRE)--Themed “Hehe Culture and A Community of Shared Future for Mankind”, the 2021…
5 years ago
BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in First-Line Chronic Lymphocytic Leukemia at the 63rd ASH Annual Meeting
BRUKINSA demonstrated superiority in progression-free survival over chemoimmunotherapy as a first-line treatment for patients with…
5 years ago
Digital Entertainment Leadership Forum’s flagship event on second day
APRU MetaGame Conference focused on education, talent, and the future of esports HONG KONG SAR…
5 years ago
Valemetostat Pivotal Data Shows Promising Response Rates in Patients with Adult T-Cell Leukemia/Lymphoma
Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory…
5 years ago